“HbA1c: The Leading Biomarker in Predicting Non-Alcoholic Fatty Liver Disease Severity”
“HbA1c: The Leading Biomarker in Predicting Non-Alcoholic Fatty Liver Disease Severity” OverviewGlobally, non-alcoholic fatty liver disease, or NAFLD, is becoming a major health concern. Non-alcoholic steatohepatitis (NASH), liver fibrosis, and cirrhosis are more serious disorders that can develop from NAFLD, which is frequently associated with obesity and metabolic syndrome. Effective management of non-alcoholic fatty liver … Read more